Correction to: Leukemia (2005) 19, 1267–1269. doi: 10.1038/sj.leu.2403775
It has been realised by the authors that incorrect labelling has been used in Figure 1b right panel (ligplot of the intermediate conformation), the labelling should read: the aspartate that hydrogen bonds the hydroxyl group of BMS is D325 and not D381 as printed. Please find below the correct labelling and figure.
Figure 1
The authors apologise for this error.
Additional information
The online version of the original article can be found at 10.1038/sj.leu.2403775
Rights and permissions
About this article
Cite this article
Gambacorti-Passerini, C., Gasser, M., Ahmed, S. et al. Erratum: Abl inhibitor BMS354825 binding mode in Ableson kinase revealed by molecular docking studies. Leukemia 19, 2023 (2005). https://doi.org/10.1038/sj.leu.2403990
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403990
